Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BE TOGETHER: Bimekizumab vs Ustekinumab in Pediatric Plaque Psoriasis
NCT06425549Phase 3Active, not recruiting
- Sponsor
- UCB
- Start
- Jun 2024
- Primary completion
- Aug 2028
- Countries
- 10
01
Overview
A Phase 3 trial of bimekizumab in plaque psoriasis, sponsored by UCB. Started Jun 2024; status: active, not recruiting.
02
Drugs
bimekizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06425549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06425549.